Lupus erythematosus generally refers to systemic lupus erythematosus (SLE), which may affect the life expectancy of male patients, depending on the severity of the disease and whether it is treated regularly.
SLE is a connective tissue disease that can involve the skin, joints, muscles, and several organs, and is most common in women of childbearing age. Whether SLE affects life expectancy depends on the severity of the disease and whether it is treated regularly.
In patients with simple involvement of skin, muscles and joints, and no involvement of internal organs, the disease can be controlled and stabilized in the long term with active and regular treatment, and generally does not affect the patient’s life expectancy. Patients with SLE that involves vital organs such as the kidneys, brain, heart and lungs generally have a poorer prognosis, which may affect their life expectancy.
It is recommended that SLE patients go to the Department of Rheumatology and Immunology of regular hospitals for consultation, standardized diagnosis and treatment under the guidance of doctors, and regular follow-up.